معرفی
Dr. Gary V. Désir serves as the Paul B. Beeson Professor of Medicine, Chair of the Department of Internal Medicine, and Vice Provost for Faculty Development at Yale University. He is also Chief of Internal Medicine at Yale New Haven Hospital, with research spanning molecular physiology, diabetes, cancer signaling, and health equity initiatives.
- Yale School of Medicine
- Department of Internal Medicine
- Co-founder, MORE (Minority Organization for Retention and Expansion)
- Scientific Founder, Two Biotech Companies
Research Interests: Discovery of renalase (cardiovascular regulator and cancer therapeutic target) and voltage-gated potassium channels in metabolic disorders. Current work focuses on renalase inhibitors for first-in-class cancer treatments.
Key Article Trends: Recent publications emphasize renalase's role in
- immune checkpoint modulation
- COVID-19 mortality prediction
- post-ERCP pancreatitis
- pediatric hypertension consequences
- visceral pain mechanisms
- macrophage-mediated organ repair
Scientific Recognition:
- 2019 Elected Member, American Clinical and Climatological Association
- 2019 Southern Connecticut Black Nurses Association Community Service Award
- 2018 Trailblazer Award, Jamaican American Connection
- 2017 Groundbreaker Award, Alpha Phi Alpha
Leadership & Diversity: As Yale's first African-descent department chair in medicine, he co-founded MORE to enhance faculty diversity through mentoring and network-building. Collaborates with Yale Institute for Global Health on Haitian healthcare projects.